• Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States

    6 days ago - By San Diego Biotechnology

    SAN DIEGO, May 19, 2020 /PRNewswire/ - Invivoscribe to offer the LeukoStrat® CDx FLT3 Mutation Assay as an FDA approved kit with analysis software.
    In 2017, Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay became the first FDA approved FLT3......
    Read more ...